Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: Am J Transplant. 2014 Aug 4;14(9):2173–2180. doi: 10.1111/ajt.12799

Figure 1. Structure of AZD8055.

Figure 1

The chemical structure of the ATP-competitive mTOR kinase inhibitor (5-{2,4-Bis[(3S)-3-methylmorpholin-4-yl]pyrido[2,3-d]pyrimidin-7-yl}-2-methoxyphenyl) methanol (AZD8055), compared with that of rapamycin.